This site is intended for Healthcare Professionals only.

NHS marks ‘Alpelisib’ as 100th fast-tracked cancer drug

Date:

Share post:

The drug, alpelisib, which is the 100th cancer drug that has being fast-tracked to patients under the NHS Cancer Drugs Fund (CDF) will be used in combination with the hormone therapy, fulvestrant, to target the gene that causes fast-growing tumours.

Up to 3,000 people a year with a certain type of secondary breast cancer will benefit from the treatment.

The approach has contributed to people in England having access to nearly one third more cancer drugs compared to the European average.

The drug which is manufactured by pharmaceutical company Novartis, is part of a growing number of precision treatments that target a tumor based on mutations in its DNA and that the NHS is rolling out.

John Stewart, NHS National Director for Specialized Commissioning said, “In just over five years, more than 80,000 people have benefitted from earlier access to a range of cancer drugs, with people in England having access to nearly one third more cancer drugs compared to the European average, and this latest innovative new treatment will help up to 3,000 more to live a better quality of life.

“This life-extending breast cancer treatment is the 100th to be rapidly made available to NHS patients thanks to the Cancer Drugs Fund, and will help people with secondary breast cancer to live longer.”

Breast cancer patients that have received prior treatment with an endocrine and CDK4/6 inhibitor will be able to benefit from this treatment on the NHS after the medicines regulator, the MHRA, extended the license for the treatment in December 2021.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

Knights Pharmacy expands footprint in South Wales with acquisition of 2 new pharmacies

Knights pharmacy to provide independent prescribing services at the new locations in South Wales Knights Pharmacy has significantly expanded...

Pharmacy bodies respond to Labour Party manifesto promises on community pharmacy

Pharmacy leaders have urged funding boost for pharmacies in response to Labour's ambitious healthcare plans The Labour Party's election...

RPS calls on political leaders to end prescription charges for long-term conditions

RPS and PCC urge political leaders to urgently get rid of prescription charges for chronic conditions on the...

Corsodyl unveils new toothpaste and mouthwash range targeted at preventing gum problems

New Corsodyl Gum Strength & Protect line includes clinically proven formulas to enhance gum health and prevent issues With...